Company profile OCGN
There is not enough data for ocugen -stock -company to provide analysis
There is not enough data for ocugen -stock -company to provide correlation calculation
There is not enough data for ocugen -stock -company to provide analysis
There is not enough data for gene therapy for blindness -stock to provide analysis
There is not enough data for gene therapy for blindness -stock to provide correlation calculation
There is not enough data for gene therapy for blindness -stock to provide analysis
After 38 days of this quarter the interest is at 34.0. Based on that we can calculate that during remaining 53 days it will total up to 81.0. retinitis pigmentosa treatment expected interest is significantly lower compared to previous quarter (-79.8%) and same quarter last year (-85.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 89 | 300 237.1% QoQ | 262 -12.7% QoQ | 284 8.4% QoQ |
| 2020 | 318 257.3% YoY 12.0% QoQ | 127 -57.7% YoY -60.1% QoQ | 217 -17.2% YoY 70.9% QoQ | 229 -19.4% YoY 5.5% QoQ |
| 2021 | 205 -35.5% YoY -10.5% QoQ | 193 52.0% YoY -5.9% QoQ | 355 63.6% YoY 83.9% QoQ | 580 153.3% YoY 63.4% QoQ |
| 2022 | 424 106.8% YoY -26.9% QoQ | 413 114.0% YoY -2.6% QoQ | 360 1.4% YoY -12.8% QoQ | 379 -34.7% YoY 5.3% QoQ |
| 2023 | 548 29.2% YoY 44.6% QoQ | 437 5.8% YoY -20.3% QoQ | 153 -57.5% YoY -65.0% QoQ | 401 5.8% YoY 162.1% QoQ |
| 2024 | 34 -93.8% YoY -91.5% QoQ | - | - | - |
The average 5 years interest of retinitis pigmentosa treatment was 24.26 per week. The last year interest of retinitis pigmentosa treatment compared to the last 5 years has changed by 13.52%. The interest for retinitis pigmentosa treatment is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 30.34%.
There is not enough data for leber congenital amaurosis cure to provide analysis
There is not enough data for leber congenital amaurosis cure to provide correlation calculation
There is not enough data for leber congenital amaurosis cure to provide analysis
After 38 days of this quarter the interest is at 107.0. Based on that we can calculate that during remaining 53 days it will total up to 256.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 112 | 185 65.2% QoQ | 221 19.5% QoQ | 53 -76.0% QoQ |
| 2020 | 18 -83.9% YoY -66.0% QoQ | 102 -44.9% YoY 466.7% QoQ | 93 -57.9% YoY -8.8% QoQ | 181 241.5% YoY 94.6% QoQ |
| 2021 | 142 688.9% YoY -21.5% QoQ | 232 127.5% YoY 63.4% QoQ | 219 135.5% YoY -5.6% QoQ | 108 -40.3% YoY -50.7% QoQ |
| 2022 | 60 -57.7% YoY -44.4% QoQ | 28 -87.9% YoY -53.3% QoQ | 121 -44.7% YoY 332.1% QoQ | 278 157.4% YoY 129.8% QoQ |
| 2023 | 197 228.3% YoY -29.1% QoQ | 361 1189.3% YoY 83.2% QoQ | 328 171.1% YoY -9.1% QoQ | 194 -30.2% YoY -40.9% QoQ |
| 2024 | 107 -45.7% YoY -44.8% QoQ | - | - | - |
The average 5 years interest of dry AMD treatment was 12.85 per week. The last year interest of dry AMD treatment compared to the last 5 years has changed by 72.84%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 96.03%.
After 39 days of this quarter the interest is at 94.0. Based on that we can calculate that during remaining 52 days it will total up to 219.0. diabetic macular edema treatment expected interest is significantly higher compared to previous quarter (+271.2%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 56 | 0 -100.0% QoQ | 202 inf% QoQ | 279 38.1% QoQ |
| 2020 | 55 -1.8% YoY -80.3% QoQ | 203 inf% YoY 269.1% QoQ | 58 -71.3% YoY -71.4% QoQ | 137 -50.9% YoY 136.2% QoQ |
| 2021 | 57 3.6% YoY -58.4% QoQ | 50 -75.4% YoY -12.3% QoQ | 60 3.4% YoY 20.0% QoQ | 109 -20.4% YoY 81.7% QoQ |
| 2022 | 262 359.6% YoY 140.4% QoQ | 116 132.0% YoY -55.7% QoQ | 73 21.7% YoY -37.1% QoQ | 167 53.2% YoY 128.8% QoQ |
| 2023 | 250 -4.6% YoY 49.7% QoQ | 174 50.0% YoY -30.4% QoQ | 69 -5.5% YoY -60.3% QoQ | 59 -64.7% YoY -14.5% QoQ |
| 2024 | 94 -62.4% YoY 59.3% QoQ | - | - | - |
The average 5 years interest of diabetic macular edema treatment was 9.69 per week. The last year interest of diabetic macular edema treatment compared to the last 5 years has changed by 8.36%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -4.72%.
After 39 days of this quarter the interest is at 135.0. Based on that we can calculate that during remaining 52 days it will total up to 315.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 121 | 285 135.5% QoQ | 274 -3.9% QoQ | 352 28.5% QoQ |
| 2020 | 300 147.9% YoY -14.8% QoQ | 290 1.8% YoY -3.3% QoQ | 296 8.0% YoY 2.1% QoQ | 293 -16.8% YoY -1.0% QoQ |
| 2021 | 202 -32.7% YoY -31.1% QoQ | 286 -1.4% YoY 41.6% QoQ | 252 -14.9% YoY -11.9% QoQ | 377 28.7% YoY 49.6% QoQ |
| 2022 | 309 53.0% YoY -18.0% QoQ | 354 23.8% YoY 14.6% QoQ | 245 -2.8% YoY -30.8% QoQ | 314 -16.7% YoY 28.2% QoQ |
| 2023 | 420 35.9% YoY 33.8% QoQ | 328 -7.3% YoY -21.9% QoQ | 305 24.5% YoY -7.0% QoQ | 326 3.8% YoY 6.9% QoQ |
| 2024 | 135 -67.9% YoY -58.6% QoQ | - | - | - |
The average 5 years interest of diabetic retinopathy treatment was 23.23 per week. The last year interest of diabetic retinopathy treatment compared to the last 5 years has changed by 14.72%. The interest for diabetic retinopathy treatment is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 17.66%.
After 38 days of this quarter the interest is at 88.0. Based on that we can calculate that during remaining 53 days it will total up to 211.0. wet AMD treatment expected interest is significantly higher compared to same quarter last year (+42.6%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 133 inf% QoQ | 134 0.8% QoQ | 160 19.4% QoQ |
| 2020 | 122 inf% YoY -23.8% QoQ | 65 -51.1% YoY -46.7% QoQ | 112 -16.4% YoY 72.3% QoQ | 158 -1.2% YoY 41.1% QoQ |
| 2021 | 77 -36.9% YoY -51.3% QoQ | 36 -44.6% YoY -53.2% QoQ | 118 5.4% YoY 227.8% QoQ | 153 -3.2% YoY 29.7% QoQ |
| 2022 | 76 -1.3% YoY -50.3% QoQ | 152 322.2% YoY 100.0% QoQ | 147 24.6% YoY -3.3% QoQ | 295 92.8% YoY 100.7% QoQ |
| 2023 | 148 94.7% YoY -49.8% QoQ | 582 282.9% YoY 293.2% QoQ | 299 103.4% YoY -48.6% QoQ | 220 -25.4% YoY -26.4% QoQ |
| 2024 | 88 -40.5% YoY -60.0% QoQ | - | - | - |
The average 5 years interest of wet AMD treatment was 12.6 per week. The last year interest of wet AMD treatment compared to the last 5 years has changed by 99.92%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 166.28%.
There is not enough data for ocugen pipeline to provide analysis
There is not enough data for ocugen pipeline to provide correlation calculation
There is not enough data for ocugen pipeline to provide analysis
There is not enough data for ocugen gene therapy. to provide analysis
There is not enough data for ocugen gene therapy. to provide correlation calculation
There is not enough data for ocugen gene therapy. to provide analysis